Cargando…
P115: REAL-WORLD DATA ON THE EFFICACY OF PHARMACEUTICAL-GRADE L-GLUTAMINE IN PREVENTING SICKLE CELL DISEASE-RELATED ACUTE COMPLICATIONS AND HEMOLYSIS IN PEDIATRIC AND ADULT PATIENTS.
Autores principales: | Elenga, N, Loko, G, Etienne-Julan, M, AlOkka, R, Adel, A, Yassin, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811860/ http://dx.doi.org/10.1097/01.HS9.0000821552.41573.26 |
Ejemplares similares
-
P1503: REAL WORLD DATA ON EFFICACY OF PHARMACEUTICAL-GRADE L-GLUTAMINE IN PREVENTING SICKLE CELL DISEASE-RELATED ACUTE COMPLICATIONS AND HEMOLYSIS IN PEDIATRIC AND ADULT PATIENTS.
por: Elenga, N., et al.
Publicado: (2022) -
Real-World data on efficacy of L-glutamine in preventing sickle cell disease-related complications in pediatric and adult patients
por: Elenga, Narcisse, et al.
Publicado: (2022) -
PB2529: RENAL FUNCTIONS EVOLUTION OF 6 SCD PATIENTS TREATED BY L-GLUTAMINE PHARMACEUTICAL GRADE FOR 30 MONTHS: A REAL-WORLD STUDY.
por: Yassin, Mohamed, et al.
Publicado: (2023) -
Fetal hemoglobin and hemolysis markers in sickle cell anemia()
por: Colella, Marina Pereira, et al.
Publicado: (2015) -
Selenium Status and Hemolysis in Sickle Cell Disease Patients
por: Delesderrier, Emília, et al.
Publicado: (2019)